SHAPING THE FUTURE WITH THE SWIRLING FLOW® STENT
n (Life Sciences & Allied Applications / Biology) the mimicking of life using imitation biological systems
13 December 2018
Veryan Medical Ltd. and Otsuka Medical Devices Co., Ltd. a 100% subsidiary of Otsuka Holdings Co., Ltd.,
today announce the completion of the acquisition of Veryan by Otsuka Medical Devices through its
UK subsidiary Otsuka Medical Devices UK Ltd.
IMPROVING PERFORMANCE BY IMITATING THE NATURAL 3D HELICAL SHAPE OF THE VASCULAR SYSTEM
Veryan has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry; developing structures that imitate those occurring naturally. Veryan’s vascular biomimetic stent technology involves adapting a straight stent design to a three-dimensional helical shape, which more closely mimics the natural geometry of the human vascular system. The BioMimics 3D stent belongs to a new generation of self-expanding stent design with advanced biomechanical and flow performance properties, creating the potential to transform the treatment of patients with symptomatic peripheral arterial disease of the lower limbs. This highly differentiated technology has been clinically proven in a multicentre, randomised clinical trial (the MIMICS study) and an FDA Investigational Device Exemption (IDE) multicentre clinical study conducted in US, Germany and Japan (MIMICS-2) and received CE Mark approval in November 2012 and US Premarket Approval (PMA) in October 2018 .